WeVote
Log In

Bill

Bill

HB 427

Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership

2026 Regular Session Introduced by Heather Bagnall Tudball and 9 co-sponsors

Maryland extends task force studying natural psychedelics' therapeutic potential and regulatory framework to develop state policy on promising psychiatric treatments.

Approved by the Governor - Chapter 207
0
WeVote Research Nonpartisan
Bill Summary · HB 427

Legislative bill overview

HB 427 extends Maryland's Task Force on Responsible Use of Natural Psychedelic Substances, which was established to study the therapeutic potential and regulatory framework for natural psychedelics like psilocybin and psilocyn. The bill likely continues the task force's operations, research mandate, and deadline for reporting findings to the legislature.

Why is this important

Psychedelic-assisted therapy has shown promising clinical results for treating depression, PTSD, and end-of-life anxiety, but remains federally controlled. Maryland's task force allows the state to develop evidence-based policy independent of federal restrictions, potentially positioning it as a leader in psychedelic medicine regulation and informing future state legislation.

Potential points of contention

  • Federal-state conflict: Natural psychedelics remain Schedule I substances federally; state task forces studying them may create legal ambiguity or face federal pushback
  • Therapeutic claims vs. evidence: While research is promising, controlled studies are limited; claims about medical benefits require careful scientific framing to avoid overpromising
  • Implementation concerns: Task force recommendations may conflict with law enforcement priorities or raise questions about how regulated use would actually be implemented at medical facilities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.